SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-12-000266
Filing Date
2012-02-13
Accepted
2012-02-13 17:15:53
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohr_10q-123111.htm 10-Q 673034
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 15403
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 16017
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 7458
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-32_2.htm EX-32.2 7766
  Complete submission text file 0001387131-12-000266.txt   720854
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-88480 | Film No.: 12600283
SIC: 2834 Pharmaceutical Preparations